Scribd
Upload
81 views2 pages

Drug-Study Palivizumab

This document provides information about the drug Palivizumab (Synagis), including its indications, dosage, side effects, adverse effects, contraindications, and nursing responsibilities. Palivizumab is a monoclonal antibody used to prevent serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in children at high risk. It is dosed at 15 mg/kg intramuscularly monthly during RSV season to prevent infection. Potential side effects include fever, pain, and redness or swelling at the injection site. Nurses are responsible for monitoring patients for changes in vital signs, oxygenation, and hydration status.

Uploaded by

Irize Denaga
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
81 views2 pages

Drug-Study Palivizumab

This document provides information about the drug Palivizumab (Synagis), including its indications, dosage, side effects, adverse effects, contraindications, and nursing responsibilities. Palivizumab is a monoclonal antibody used to prevent serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in children at high risk. It is dosed at 15 mg/kg intramuscularly monthly during RSV season to prevent infection. Potential side effects include fever, pain, and redness or swelling at the injection site. Nurses are responsible for monitoring patients for changes in vital signs, oxygenation, and hydration status.

Uploaded by

Irize Denaga
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 2

DRUG INDICATIONS DOSAGE SIDE EFFECTS ADVERSE EFFECT CONTRAINDICATION NURSING

S RESPONSIBILITIES

Generic Name: To prevent Children: 15 CNS:nervousness,pain. Contraindicated in  Monitor the


 Fever or pain children
Palivizumab serious lower mg/kg I.M respiration and
respiratory monthly through  redness/ EENT: otitis media, rhinitis, hypersensitive to oxygenation of the
out RSV season ( pharyngitis, sinusitis, drug or its patient.
tract disease swelling at the components.
November to april conjunctivitis.  Provide oxygen if
caused by
Brand Name: in the northern injection site saturations are
Synagis respiratory GI: diarrhea, vomiting, low.
hemisphere).Give may occur
syncytial gastroenteritis,oral  Assess vital signs.
first dose before
virus(RSV) in candidiasis.  Maintain oral
start of RSV
children at high hydration.
season.
Drug Class: risk. Hematologic: anemia  Instructs patient pr
monoclonal guardian of the
antibodies Skin:Rash, fungal, patient to notify
dermititis, their primary
eczema,seborrhea. health care
provider Of any
Other: hernia, failure to change in the color
thrive, injection site consistency of
reaction,viral infection, flu their secretions.
syndrome.  Offer smaller more
frequent oral
foods.

You might also like